Lupin Limited has informed the Exchange regarding a press release dated January 14, 2024, titled "Lupin Receives Approval from U.S. FDA for Propranolol Hydrochloride Extended-Release Capsules USP".
Lupin Limited has informed the Exchange regarding a press release dated January 14, 2024, titled "Lupin Receives Approval from U.S. FDA for Propranolol Hydrochloride Extended-Release Capsules USP".